Skip to main content
Retour
Watch Compare

PUMA BIOTECHNOLOGY, INC.

Qualité des données : 100%
PBYI
Nasdaq Manufacturing Chemicals
7,78 €
▼ 0,02 € (-0,26%)
Cap. Boursière: 392,26 M
Prix
7,71 €
Cap. Boursière
392,26 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -2,54% annually over 5 years
ROE of 28,28% indicates high profitability
Debt/Equity of 0,30 — conservative balance sheet
Generating 41,73 M in free cash flow
P/E of 12,61 — trading at a low valuation
Cash machine — converts 134,14% of earnings into free cash flow

Croissance

Revenue Growth (5Y)
-2,54%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-0,91%
Earnings (1Y)2,75%
FCF Growth (3Y)24,62%

Qualité

Return on Equity
28,28%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC27,49%
Net Margin13,62%
Op. Margin16,33%

Sécurité

Debt / Equity
0,30
En dessous de la moyenne du secteur (0,30)
Current Ratio1,74
Interest Coverage5,63

Valorisation

PE (TTM|2027)
12,61 | 11,86
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio3,40
EV/EBITDA7,73
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 12,6 -1,5
P/B 3,4 1,6
ROE % 28,3 -53,5
Net Margin % 13,6 -41,5
Rev Growth 5Y % -2,5 1,8
D/E 0,3 0,3

Objectif de Cours des Analystes

1 analyste
Hold
Actuel
7,78 €
-35.7%
Objectif
5,00 €
5,00 €
5,00 €
5,00 €
Prévisions
P/E Prévisionnel 11,97
BPA Prévisionnel 0,65 €
Croissance BPA (est.) +62,5%
CA Est. 218,00 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,65 €
0,65 € – 0,65 €
 218,00 M 1
FY2026 0,40 €
0,40 € – 0,40 €
 218,00 M 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 0,23 € 0,29 € +26,1%
Q32025 0,09 € 0,21 € +133,3%
Q22025 0,07 € 0,15 € +114,3%
Q12025 0,03 € 0,10 € +300,0%

ETFs Holding This Stock

BRUSX BRUSX
1,14% weight
LMBAX LMBAX
0,30% weight
LMBCX LMBCX
0,30% weight
LMBRX LMBRX
0,30% weight
LMBMX LMBMX
0,30% weight
LGSCX LGSCX
0,30% weight
LMSIX LMSIX
0,30% weight
SQLV logo SQLV Royce Quant Small-Cap Quality Value ETF
0,30% weight
TSVAX TSVAX
0,27% weight
PSVKX PSVKX
0,27% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -0,91% Revenue Growth (3Y) -1,55%
Earnings Growth (1Y) 2,75% Earnings Growth (3Y) 20,04%
Revenue Growth (5Y) -2,54% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 228,37 M Net Income (TTM) 31,11 M
ROE 28,28% ROA 15,64%
Gross Margin N/A Operating Margin 16,33%
Net Margin 13,62% Free Cash Flow (TTM) 41,73 M
ROIC 27,49% FCF Growth (3Y) 24,62%
Safety
Debt / Equity 0,30 Current Ratio 1,74
Interest Coverage 5,63 Asset Turnover 1,15
Working Capital 60,85 M Tangible Book Value 115,27 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 12,61 Forward P/E N/A
P/B Ratio 3,40 P/S Ratio 1,72
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 7,73 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 10,64%
Market Cap 392,26 M Enterprise Value 372,74 M
Per Share
EPS (Diluted TTM) 0,61 Revenue / Share 4,49
FCF / Share 0,82 OCF / Share 0,82
EPS CAGR (1Y) -1,61% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,03% FCF Conversion 134,14%
SBC-Adj. FCF 34,03 M Growth Momentum 1,63

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 228,37 M 230,47 M 235,64 M 228,03 M 253,16 M
Net Income 31,11 M 30,28 M 21,59 M 2 000,0 -29,13 M
EPS (Diluted) 0,61 0,62 0,45 0,00 —
Gross Profit — — — — —
Operating Income 37,30 M 30,97 M 32,64 M 23,72 M 1,29 M
EBITDA — — — — —
R&D Expenses — — — — 71,87 M
SG&A Expenses 70,85 M 80,16 M 89,93 M 89,98 M 116,29 M
D&A 10,94 M 11,52 M 11,52 M 8,92 M 10,60 M
Interest Expense 6,62 M 12,45 M 13,33 M 11,59 M 12,81 M
Income Tax 4,67 M -6,18 M 1,08 M 455 000,0 324 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 216,30 M 213,33 M 230,53 M 222,06 M 226,59 M
Total Liabilities 85,96 M 121,21 M 177,09 M 200,45 M 229,03 M
Shareholders' Equity 130,34 M 92,13 M 53,44 M 21,61 M -2,45 M
Total Debt 22,68 M 68,00 M 102,00 M 102,00 M 102,00 M
Cash & Equivalents 29,64 M 69,22 M 84,59 M 76,20 M 63,13 M
Current Assets 162,69 M 147,66 M 156,19 M 134,28 M 140,02 M
Current Liabilities 81,25 M 96,11 M 99,38 M 77,48 M 109,59 M